ETrade Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,357
| Closed | -$731K | – | 858 |
|
|
2019
Q3 | $731K | Sell |
7,357
-122
| -2% | -$11.6K | 0.02% | 439 |
|
|
2019
Q2 | $691K | Sell |
7,479
-2,047
| -21% | -$194K | 0.02% | 456 |
|
|
2019
Q1 | $899K | Sell |
9,526
-2,607
| -21% | -$228K | 0.03% | 359 |
|
|
2018
Q4 | $778K | Buy |
12,133
+893
| +8% | +$65.9K | 0.03% | 373 |
|
|
2018
Q3 | $1.01M | Buy |
11,240
+4,049
| +56% | +$358K | 0.03% | 363 |
|
|
2018
Q2 | $571K | Sell |
7,191
-14,191
| -66% | -$1.18M | 0.02% | 497 |
|
|
2018
Q1 | $1.91M | Sell |
21,382
-4,042
| -16% | -$388K | 0.06% | 188 |
|
|
2017
Q4 | $2.65M | Sell |
25,424
-3,446
| -12% | -$389K | 0.09% | 135 |
|
|
2017
Q3 | $4.21M | Sell |
28,870
-78
| -0.3% | -$10.6K | 0.15% | 70 |
|
|
2017
Q2 | $3.76M | Buy |
28,948
+1,631
| +6% | +$200K | 0.15% | 75 |
|
|
2017
Q1 | $3.4M | Buy |
27,317
+1,453
| +6% | +$174K | 0.14% | 83 |
|
|
2016
Q4 | $2.99M | Buy |
25,864
+1,003
| +4% | +$112K | 0.14% | 85 |
|
|
2016
Q3 | $2.6M | Sell |
24,861
-573
| -2% | -$62K | 0.13% | 92 |
|
|
2016
Q2 | $2.51M | Sell |
25,434
-210
| -0.8% | -$21.7K | 0.13% | 91 |
|
|
2016
Q1 | $2.57M | Sell |
25,644
-942
| -4% | -$97K | 0.15% | 73 |
|
|
2015
Q4 | $3.18M | Buy |
26,586
+344
| +1% | +$39.8K | 0.19% | 55 |
|
|
2015
Q3 | $2.84M | Buy |
26,242
+599
| +2% | +$74.3K | 0.17% | 64 |
|
|
2015
Q2 | $2.97M | Buy |
25,643
+118
| +0.5% | +$13.5K | 0.17% | 59 |
|
|
2015
Q1 | $2.94M | Buy |
25,525
+507
| +2% | +$60.6K | 0.17% | 59 |
|
|
2014
Q4 | $2.8M | Buy |
25,018
+523
| +2% | +$55.2K | 0.17% | 57 |
|
|
2014
Q3 | $2.32M | Buy |
24,495
+79
| +0.3% | +$7.13K | 0.15% | 67 |
|
|
2014
Q2 | $2.1M | Buy |
24,416
+2,228
| +10% | +$169K | 0.14% | 91 |
|
|
2014
Q1 | $1.55M | Buy |
22,188
+3,758
| +20% | +$298K | 0.11% | 128 |
|
|
2013
Q4 | $1.56M | Buy |
18,430
+3,774
| +26% | +$299K | 0.12% | 103 |
|
|
2013
Q3 | $1.13M | Buy |
14,656
+2,454
| +20% | +$172K | 0.1% | 114 |
|
|
2013
Q2 | $714K | Buy |
+12,202
| New | +$734K | 0.08% | 151 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
ETrade Capital Management's CELG Position: Q4 2019 in Review
ETrade Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,357 shares — an estimated $731K sold.
ETrade Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.21M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- ETrade Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- ETrade Capital Management sold 7,357 Celgene Corp shares in Q4 2019, an estimated $731K.
- ETrade Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- ETrade Capital Management's Celgene Corp position peaked at $4.21M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on ETrade Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.